Latest News From Veterinary Regulations

Iowa Gov. Kim Reynolds announced $40 million in funding to help complete Phase 2 of Iowa State University’s Veterinary Diagnostic Laboratory. Here's why it matters to all of animal agriculture.

The effective date of the decision is Feb. 21, which means that the FDA will again hold veterinarians to the federal requirements for the veterinarian-client-patient relationship beginning on that date

“ACTPs have the potential to make significant changes in how we treat diseases and may provide novel therapies for unmet therapeutic needs of animals,” reports Dr. Janet Woodcock, Acting Commissioner of the FDA.

The agency says the information is being provided “in an effort to improve transparency and communication with veterinarians and the public.”

The agency announced it will not finalize a plan introduced by the Trump Administration, instead handing control of rulemaking to its Animal and Plant Health Inspection Service.

Research needed to help define duration of use for certain medically important antimicrobial drugs for food animals.

Market forces and regulatory actions will drive emphasis on disease prevention and antibiotic stewardship.

Market forces and regulatory actions will drive emphasis on disease prevention and antibiotic stewardship.

As we enter a new year and a new decade, antibiotic stewardship remains on the top of issues affecting food-animal veterinarians.

FDA’s annual summary report on antimicrobial sales for use in food animals shows a small year-over-year increase in 2018, but the total remains well below pre-VFD levels.

Kansas State University's Olathe campus is now offering a premier graduate certificate designed for the regulatory affairs sector of the animal health industry.

The Washington State Department of Agriculture (WSDA) is now offering Washington ranchers a quicker, more cost-effective way to report cattle sales and out-of-state movement of their cattle.

Over the past few years, cannabidiol (CBD) has become wildly popular as a dietary supplement and “natural” treatment for a laundry list of health conditions in humans and animals.

On November 21, 2019, at 1:00-2:30 p.m. EST, the FDA's Center for Veterinary Medicine will hold a public webinar about the agency’s newly-released draft Guidance for Industry #256.

Animal drug compounding can provide tailored treatments for patients or conditions not easily addressed with FDA-approved drugs, but the practice also entails some risks.

Updates to navigation and functionality affect all GVL users.

The United States Animal Health Association (USAHA), the nation's animal health forum for over a century, is holding its 123rd annual meeting in Providence, Rhode Island, from Oct. 24-30. I

Behind the scenes, animal health officials are working on behalf of producers and the livestock industry.

Performance measures track the progress of the Center of Veterinary Medicine’s (CVM) Five-Year Plan for Supporting Antimicrobial Stewardship in Veterinary Settings.

Expanded conditional approval has the potential to incentivize drug development and provide veterinarians with legally marketed new animal drugs.

Proposal would bring remaining approved over-the-counter medically important antimicrobial drugs used for animals under veterinary oversight.

The proposal would bring remaining approved over-the-counter medically important antimicrobial drugs used for animals under veterinary oversight.

On September 11, 2019, the FDA extended the comment period for its request for public input on zero-day withdrawal periods and zero-day milk discard times for animal drugs.

On August 29, FDA released its first report on inspection and compliance activities.

The FDA has issued a new Guidance for Industry (GFI #181), which provides content and format regulations for the representative “Blue Bird” labeling to be used for Type B and Type C medicated feeds.

The FDA’s Center for Veterinary Medicine this week issued a final rule, “New Animal Drugs; Updating Tolerances for Residues of New Animal Drugs in Food.”

The U.S. Food and Drug Administration has approved Monovet 90, manufactured by Huvepharma EOOD, the first generic monensin for use in cattle and goats.

The Texas Animal Health Commission (TAHC) has proposed a Bovine Viral Diarrhea Virus (BVDV) control program, including designating BVDV as a reportable disease.

New data from the National Animal Health Monitoring System (NAHMS) provides a baseline for antibiotic trends in food animal during 2016, prior to implementation of key rule changes.

The USDA's Animal and Plant Health Inspection Service has finalized the Chronic Wasting Disease Herd Certification Program Standards that were originally published on March 29, 2018 for stakeholder feedback.

In late March, FDA released its draft Guidance for Industry 120, which aims to address questions that emerged since implementation of the current Veterinary Feed Directive rules in 2017.

When the FDA issued its final VFD rules back in 2015, they also released a draft guidance for industry offering answers to anticipated questions regarding application of the rules in common and unusual circumstances.

The Center for Food Security and Public Health at the Iowa State University College of Veterinary Medicine has launched updated versions of two of its online veterinary immunology and principles of vaccinology courses.

The United States Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) launched an interactive website that provides livestock producers with important information.

Earlier this year, the FDA provided updates to its Draft Guidance for Industry (GFI) 120, based on stakeholder questions regarding details around the veterinary feed directive (VFD) rules.

In recent months, APHIS has revised the Animal Disease Traceability program standards for approving new tags entering the market.

For years, the USDA has used a “tiered” system for claims on vaccine labels, which added complexity to pre-license trials and tended to create confusion for users.

Based on comments received regarding a proposed rule, USDA’s Animal and Plant Health Inspection Service (APHIS) announced this week it will partially withdraw the proposal.

When the FDA issued its final veterinary feed directive (VFD) rules back in 2015, they also released a draft guidance for industry (GFI) offering answers to anticipated questions.

The U.S. Department of Agriculture’s (USDA) Animal Plant Health and Inspection Service (APHIS) is updating its scrapie regulations and program standards. 

Efforts toward improving stewardship of antibiotics in livestock production have gained momentum worldwide, with more countries regulating antibiotic use and collecting data to document trends.

Our editorial team has developed a comprehensive package of content focused on Cannabis and its potential across U.S. agriculture.

U.S. sales of medically important antimicrobials for use in food animals dropped considerably last year according to the latest summary report from the FDA. The decline in 2017 accelerated a trend that began in 2016.

U.S. sales of medically important antimicrobials for use in food animals dropped considerably last year according to the latest summary report from the FDA. The decline in 2017 accelerated a trend that began in 2016.

The USDA’s Animal and Plant Health Inspection Service (APHIS) has published a final rule updating requirements for identifying cattle imported to the United States from Mexico.

The FDA this week announced an open period for applications for grants to support the development of new animal drugs intended to treat uncommon diseases (minor uses) in major species, or to treat minor species (MUMS).

Plan includes cost-sharing for electronic ID, birth-to-slaughter traceability.

Follow the rules, keep good records and you shouldn’t have to worry about FDA audits.

The AVMA, AAVSB, AAVMC and NAVTA have released a statement of support for licensing requirements. These groups are working to standardize and improve licensure standards for veterinarians and veterinary technicians.

​The American Veterinary Medical Association (AVMA) applauds House and Senate lawmakers for their passage of the Animal Drug and Animal Generic Drug User Fee Amendments of 2018 (H.R. 5554/S.2434.